Kala Bio (KALA) added ~14% in early premarket trading on Wednesday after the eye drug developer announced plans to license AI capabilities to the biopharma industry in a bid to become an AI ...

Labourers at a quarry outside Mandera town where the highest infection rates of the parasitic disease Kala-Azar have been recorded — Tony KARUMBA For nearly a year, repeated misdiagnoses of the deadly ...

Kala azar (visceral leishmaniasis), also called black fever, is on the cusp of elimination in India, with a decline in cases from 77102 in 1992 to 9241 in 2014, 524 cases in 2023 and finally, to only ...

Black sesame seeds are rich in calcium and magnesium, which can nourish the body, especially for people who suffer from bone density issues. Studies indicate that the high nutritional value of black ...

Black chickpeas, or 'kala chana', have various health benefits for the whole body. Studies have confirmed that black chickpeas have a rich nutritional profile that can nourish the body with essential ...

Discover the incredible health benefits of kala chana soup, a protein-rich, fibre-packed dish perfect for vegetarians and vegans. This nutritious legume supports digestion, heart health, and weight ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Arlington biotech has been ...

Shares of KALA BIO KALA have nosedived 88.3% in a month after the company announced the failure of a mid-stage study evaluating its only clinical pipeline candidate, KPI-012, for the treatment of ...

This Navratri, Shriram Bharatiya Kala Kendra (SBKK)’s iconic dance-drama “Ram”, based on Tulsidas’s Ramcharitmanas, returns to the stage with fresh elements designed to captivate newer generations.

Kamehameha Kalaweloilehua Chock is a big-time outside hitter who has a psssion for volleyball and gathering shells from Hawaii’s shores. “Sometimes by myself, but mostly with one of my best friends, ...

KALA BIO (KALA) closed the last trading session at $7.44, gaining 35.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...